These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 311786)

  • 1. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.
    McDonagh DJ; Nathan SP; Knudson RJ; Lebowitz MD
    J Clin Invest; 1979 Feb; 63(2):299-309. PubMed ID: 311786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function.
    Eriksson S; Lindell SE; Wiberg R
    Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1-antitrypsin deficiency.
    Idell S; Cohen AB
    Clin Chest Med; 1983 Sep; 4(3):359-75. PubMed ID: 6357600
    [No Abstract]   [Full Text] [Related]  

  • 4. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on the lung function in alpha 1-antitrypsin-deficient (PiMZ) patients.
    Kambe M; Morishita K; Tsubokura T; Tsuno K; Kimura T; Utsumi T; Kawamoto H; Yamakido M; Mittman C
    Hiroshima J Med Sci; 1993 Mar; 42(1):41-5. PubMed ID: 8486520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary abnormalities in intermediate alpha-1-antitrypsin deficiency.
    Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Webb DR; Chaubey YP; Townes PL
    J Clin Invest; 1976 Nov; 58(5):1069-77. PubMed ID: 1086856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal lung function study in heterozygous PiMZ phenotype subjects.
    Tarján E; Magyar P; Váczi Z; Lantos A; Vaszár L
    Eur Respir J; 1994 Dec; 7(12):2199-204. PubMed ID: 7713204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype.
    Silva GE; Guerra S; Keim S; Barbee RA; Sherrill DL
    Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin.
    Larsson C; Dirksen H; Sundström G; Eriksson S
    Scand J Respir Dis; 1976; 57(6):267-80. PubMed ID: 1087749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
    Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
    Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?].
    Johansen S; Gulsvik A
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2142-5. PubMed ID: 2788939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The variability of clinical presentation of chronic obstructive pulmonary disease in patients with hereditary alpha-1 antitrypsin deficiency].
    Kuca P; Kamiński D; Campbell E; Kołakowski J; Goljan-Geremek A; Puścińska E; Bieleń P; Nowiński A; Wojda E; Hawryłkiewicz I; Sliwiński P; Górecka D
    Pneumonol Alergol Pol; 2004; 72(9-10):420-3. PubMed ID: 16021998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors, pulmonary function, and mortality.
    Menkes HA; Cohen BH; Beaty TH; Newill CA; Khoury MJ
    Prog Clin Biol Res; 1984; 147():501-21. PubMed ID: 6610878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1-antitrypsin deficiency in a Southland family.
    Browne RL
    N Z Med J; 1975 Nov; 82(551):291-3. PubMed ID: 1082114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Respiratory involvement in ankylosing spondylarthritis: relations to alpha-1-antitrypsin phenotypes and tobacco consumption].
    Eulry F; Marotel C; Lechevalier D; Haguenauer D; Crozes P; Magnin J
    Rev Rhum Ed Fr; 1994 Jun; 61(6):405-14. PubMed ID: 7833865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study.
    Regev A; Guaqueta C; Molina EG; Conrad A; Mishra V; Brantly ML; Torres M; De Medina M; Tzakis AG; Schiff ER
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S30-5. PubMed ID: 16819398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the pulmonary features of alpha 1-antitrypsin deficiency.
    Tobin MJ; Hutchison DC
    Arch Intern Med; 1982 Jul; 142(7):1342-8. PubMed ID: 7046673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function in heterozygotes for alpha,-antitrypsin deficiency: a case-control study.
    Buist AS; Sexton GJ; Azzam AM; Adams BE
    Am Rev Respir Dis; 1979 Oct; 120(4):759-66. PubMed ID: 315737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of alpha 1-protease inhibitor deficiency.
    Hutchison DC
    Eur Respir J Suppl; 1990 Mar; 9():29s-34s. PubMed ID: 2340048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitor phenotype BsaskatoonM is not associated with emphysema - a 20-year follow-up study.
    Jokic R; Fisher KL; Cockcroft DW
    Can Respir J; 1999; 6(5):407-11. PubMed ID: 10572206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.